Brief: Vigil Neuroscience, Inc. Q2 EPS USD -0.52.
08/08/2023 12:07
Aug 8 (Reuters) - Vigil Neuroscience, Inc. Q2 EPS USD -0.52. * Q2 operating expenses USD 21.913 million * Q2 income from operations USD -21.913 million
Recent news on Vigil Neuroscience
See all newsVigil Neuroscience Inc reports results for the quarter ended June 30 - Earnings Summary
Vigil Neuroscience Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
U.S. RESEARCH ROUNDUP-Ralph Lauren, Vigil Neuroscience, Workday
Deals of the day-Mergers and acquisitions